Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,973,405
  • Shares Outstanding, K 119,167
  • Annual Sales, $ 618,730 K
  • Annual Income, $ -255,100 K
  • 60-Month Beta 1.84
  • Price/Sales 3.82
  • Price/Cash Flow N/A
  • Price/Book 3.29
Trade TXG with:

Options Overview Details

View History
  • Implied Volatility 99.07% ( -2.70%)
  • Historical Volatility 88.73%
  • IV Percentile 97%
  • IV Rank 86.76%
  • IV High 107.98% on 06/05/24
  • IV Low 40.72% on 09/01/23
  • Put/Call Vol Ratio 3.24
  • Today's Volume 174
  • Volume Avg (30-Day) 230
  • Put/Call OI Ratio 0.49
  • Today's Open Interest 6,353
  • Open Int (30-Day) 5,668

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 18 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.46
  • Number of Estimates 7
  • High Estimate -0.34
  • Low Estimate -0.57
  • Prior Year -0.53
  • Growth Rate Est. (year over year) +13.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.28 +9.29%
on 07/10/24
20.36 -17.98%
on 06/28/24
-3.07 (-15.53%)
since 06/18/24
3-Month
15.28 +9.29%
on 07/10/24
29.37 -43.14%
on 04/30/24
-11.24 (-40.23%)
since 04/19/24
52-Week
15.28 +9.29%
on 07/10/24
63.57 -73.73%
on 07/31/23
-43.43 (-72.23%)
since 07/19/23

Most Recent Stories

More News
10x Genomics: Q1 Earnings Snapshot

10x Genomics: Q1 Earnings Snapshot

TXG : 16.70 (+0.85%)
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought

The popular money manager added to these three existing positions on Monday following disappointing financial updates earlier this month.

ROKU : 62.55 (-0.35%)
TXG : 16.70 (+0.85%)
NTLA : 25.08 (-3.87%)
10x Genomics: Q4 Earnings Snapshot

10x Genomics: Q4 Earnings Snapshot

TXG : 16.70 (+0.85%)
10x Genomics: Q3 Earnings Snapshot

10x Genomics: Q3 Earnings Snapshot

TXG : 16.70 (+0.85%)
10x Genomics to Report Third Quarter 2023 Financial Results on November 2, 2023

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today it will report financial results for the third...

TXG : 16.70 (+0.85%)
10x Genomics Comments on Second UPC Preliminary Injunction Decision

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court ("UPC")...

TXG : 16.70 (+0.85%)
NSTG : 0.1053 (-37.43%)
10x Wins Injunction From Unified Patent Court Banning Sales of NanoString's CosMx Products in Europe

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that the European Unified Patent Court ("UPC")...

TXG : 16.70 (+0.85%)
NSTG : 0.1053 (-37.43%)
10x Genomics Expands Gene Expression Flex Offering with New High-Throughput Multiomic Profiling Kit

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today the commercial availability of a new kit to...

TXG : 16.70 (+0.85%)
10x Genomics to Present at the Morgan Stanley 21st Annual Global Healthcare Conference

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will...

TXG : 16.70 (+0.85%)
10x Genomics Surpasses 100 Xenium Analyzer Shipments

/PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that it has shipped more than 100 Xenium...

TXG : 16.70 (+0.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

See More

Key Turning Points

3rd Resistance Point 17.62
2nd Resistance Point 17.25
1st Resistance Point 16.98
Last Price 16.70
1st Support Level 16.34
2nd Support Level 15.97
3rd Support Level 15.70

See More

52-Week High 63.57
Fibonacci 61.8% 45.12
Fibonacci 50% 39.42
Fibonacci 38.2% 33.73
Last Price 16.70
52-Week Low 15.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar